| Literature DB >> 34895375 |
Josip Stojic1, Vlatko Grabovac1, Marko Lucijanic2,3.
Abstract
Entities:
Year: 2021 PMID: 34895375 PMCID: PMC8692850 DOI: 10.1017/ice.2021.498
Source DB: PubMed Journal: Infect Control Hosp Epidemiol ISSN: 0899-823X Impact factor: 3.254
Overview of NSIs and Associated Parameters Prior to and During the COVID-19 Pandemic
| Variable | Prior to COVID-19 | During COVID-19 |
|
|---|---|---|---|
| No. of incidents | 74 | 60 | … |
| Nonsterile needle, n/N (%) | 66/74 (89.2) | 56/60 (93.3) | .411 |
| Other equipment, n/N (%) | 6/74 (8.1) | 4/60 (6.7) | |
| Unknown, n/N (%) | 2/74 (2.7) | 0/60 (0) | |
| Median age, years, median (IQR) | 31 (25–38) | 29 (24–38.3) | .512 |
| Sex, female, n/N (%) | 59/74 (79.7) | 40/60 (66.7) | .087 |
| Incidents per month, median (IQR) | 5 (3.25–7.5) | 5.5 (2.5–7) | .897 |
| Total no. of active activities ×1,000, median (IQR) | 54.9 (51.5–56.4) | 17.9 (9.4–29.1) |
|
| Total no. of hospitalized patients per month ×1,000, median (IQR) | 2.8 (2.7–2.9) | 1.6 (1.04–1.8) |
|
| Incidents per activity per month, median (IQR) | 8.9 (5.73–14.47) | 25.2 (11.52–78.71) |
|
| Incidents per no. of patients, median (IQR) | 1.7 (1.12–2.71) | 3.4 (1.75–6.25) |
|
| HBs-Ag positive, n/N (%) | 0/71 (0) | 1/58 (1.7) | .450 |
| Anti-HBs positive, n/N (%) | 66/71 (93) | 50/58 (86.2) | .207 |
| Anti-HBc positive, n/N (%) | 0/71 (0) | 1/58 (1.7) | .450 |
| Anti-HCV positive, n/N (%) | 2/71 (2.8) | 0/58 (0) | .501 |
| Anti-HIV positive, n/N (%) | 0/71 (0) | 0/58 (0) | 1.000 |
Note. NSIs, needlestick and sharp injuries; IQR, interquartile range; HBs-Ag, surface antigen of the hepatitis B virus; HBc, core antigen of the hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus.
Statistically significant at P < .05.